Cover Image
市場調查報告書

醫療機器人轉換的醫療保健:價格、成本效益的評估

Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment - Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle

出版商 MarketsandMarkets 商品編碼 356860
出版日期 內容資訊 英文 97 Pages
訂單完成後即時交付
價格
Back to Top
醫療機器人轉換的醫療保健:價格、成本效益的評估 Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment - Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle
出版日期: 2016年04月21日 內容資訊: 英文 97 Pages
簡介

本報告以醫療機器人為主題,提供影響機器人的價格的要素的相關調查,機器人的各類型的價格變動趨勢,醫療費償付情形,價格決策因素,影響者、決策者,及成本效益的評估等。

第1章 簡介

第2章 醫療機器人

  • 簡介
  • 樣子價值清單
    • 手術機器人
    • 復健機器人
    • 非侵襲放射線外科系統 (機器人型)
    • 醫院、藥局用機器人
  • 價格變動評估
    • 各應用領域
    • 各地區

第3章 預測的價格戰爭:手術機器人市場 (直觀性 vs. 競爭)

第4章 醫療機器人:醫療費償付情形,各地區

  • 手術機器人
  • 復健機器人
  • 非侵襲放射線外科系統 (機器人型)

第5章 醫療機器人:主要的價格決策因素

第6章 醫療機器人:資金籌措選擇的評估

  • 手術機器人
  • 復健機器人
  • 非侵襲放射線外科系統 (機器人型)
  • 醫院、藥局用機器人

第7章 醫療機器人:影響者、決策者

  • 手術機器人
  • 復健機器人
  • 非侵襲放射線外科系統 (機器人型)
  • 醫院、藥局用機器人

第8章 醫療機器人:終端用戶的主要的選擇標準

  • 手術機器人
  • 復健機器人
  • 非侵襲放射線外科系統 (機器人型)
  • 醫院、藥局用機器人

第9章 醫療機器人:購買循環評估

第10章 醫療機器人:供應商採用的行銷、推銷策略

  • 手術機器人
  • 復健機器人
  • 非侵襲放射線外科系統 (機器人型)
  • 醫院、藥局用機器人

第11章 成本效益的評估

  • 手術機器人
  • 復健機器人
  • 非侵襲放射線外科系統 (機器人型)
  • 醫院、藥局用機器人

第12章 附錄

目錄
Product Code: MD 4248

Extensive research on the price variation and cost-benefits of medical robots (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy) has brought to light the factors influencing the prices of the robots and the cost-savings achieved through investment in the expansive capital equipment. Considering the on-going and rapid change occurring in the health care industry, hospitals are focusing on various ways to increase the quality of care delivered. Aligned with this trend, healthcare providers are increasingly adopting advanced technologies that help them realize increase in patient volumes as well as increasing patient satisfaction in the form of reduced surgical pain, reduced hospital stay and follow-up, and faster recovery time.

Below is the list of some of the benefits of Medical Robots:

BENEFITS TO CLINICS AND HOSPITALS (PROVIDERS) & PATIENTS

  • Surgical Robots & Non-Invasive Radiosurgery System (robotic based): Achieve cost savings in terms of reduced pre- and post-operation care costs and length of stay at hospitals
  • Pharmacy and Hospital Robotic systems: Achieve cost-saving through reduced manpower (required for medication dispensing, packaging, and labelling) and lowering medication error through automation
  • Rehabilitation Robots: Achieve cost saving through providing self-sufficiency to the disabled by reducing expenses incurred on external help & physiotherapy

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market. Insights cited in the report will help these firms to stay competitive in the market and garner a greater market share. It will enlighten the stakeholders about the benefits of embracing medical robots. The study analyzes the total economic impact (TEI) of medical robots on organizations and highlights the transformation enabling value of a technology in increasing the effectiveness of overall business processes.

Firms purchasing the report could use the below-mentioned information for strategy development, market penetration, and product development/innovation and for strengthening respective market shares.

The report provides insights on the following pointers:

  • Pricing Variation: This section provides comprehensive information on pricing of medical robots and analyzing the price variation across application areas of each robot type and geographic price variation
  • Reimbursement Landscape Assessment: This section provides insights on the current reimbursement scenario in surgical, non-invasive radiosurgery, and hospital & pharmacy robots. Regional level data have been covered in the section
  • Major Price Determinants: This section dissects the various price determinants that guide the final pricing of a robot
  • Financing Option Assessment: This section provides exhaustive information on varied financing options available to the end users to gain access to the expensive technology
  • Key Influencers & Decision-makers: This section provides detailed information on key influencers & decision-makers that play a crucial role throughout the buying cycle right from deciding the purchase, evaluation of technologies up till the final purchase of the technology
  • Key Selection Criteria for End-Users: The section covers the criteria considered by the end-users while making purchase decisions for a robotic technology.
  • Buying Cycle Assessment: The section covers the standard buying cycle followed in medical robotic purchases and the length of buying cycle for each type of robotic technology.
  • Marketing & Promotional Strategies Adopted by Vendors: The section provides and indicative list of marketing & promotional activities followed by the vendors to increase their product visibility in the market
  • Cost-Benefit Assessment (Based on Research Studies & Expert Opinions): This section provides in-depth assessment of cost-benefit assessment covering cost benefit studies and industry opinion that provides a guideline to the stakeholders in understanding the investment structure and the cost-savings achieved through the use of each type of robot.

TABLE OF CONTENTS

1. INTRODUCTION

2. MEDICAL ROBOTS: PRICING LANDSCAPE

  • 2.1. INTRODUCTION
  • 2.2. INDICATIVE PRICE LIST
    • 2.2.1. SURGICAL ROBOTS
    • 2.2.2. REHABILITATION ROBOTS
    • 2.2.3. NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
    • 2.2.4. HOSPITAL & PHARMACY ROBOTS
  • 2.3. PRICE VARIATION ASSESSMENT
    • 2.3.1. BY APPLICATION
      • 2.3.2.1. Surgical Robots
      • 2.3.2.2. Rehabilitation Robots
      • 2.3.2.3. Non-invasive Radiosurgery Systems (Robot-based)
      • 2.3.2.4. Hospital & Pharmacy Robots
    • 2.3.2. BY GEOGRAPHY
      • 2.3.1.1. Surgical Robots
      • 2.3.1.2. Rehabilitation Robots
      • 2.3.1.3. Hospital & Pharmacy Robots
      • 2.3.1.4. Non-invasive Radiosurgery Systems (Robot-based)

3. EXPECTED PRICE WAR: SURGICAL ROBOTS MARKET (INTUITIVE VS. COMPETITION)

4. MEDICAL ROBOTS: REIMBURSEMENT LANDSCAPE, BY REGION

  • 4.1. SURGICAL ROBOTS
  • 4.2. REHABILITATION ROBOTS
  • 4.3. NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)

5. MEDICAL ROBOTS: MAJOR PRICE DETERMINANTS

6. MEDICAL ROBOTS: FINANCING OPTIONS ASSESSMENT

  • 6.1. SURGICAL ROBOTS
  • 6.2. REHABILITATION ROBOTS
  • 6.3. NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
  • 6.4. HOSPITAL & PHARMACY ROBOTS

7. MEDICAL ROBOTS: KEY INFLUNCERS & DECISION-MAKERS

  • 7.1. SURGICAL ROBOTS
  • 7.2. REHABILITATION ROBOTS
  • 7.3. NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
  • 7.4. HOSPITAL & PHARMACY ROBOTS

8. MEDICAL ROBOTS: KEY SELECTION CRITERIA FOR END-USER

  • 8.1. SURGICAL ROBOTS
  • 8.2. REHABILITATION ROBOTS
  • 8.3. NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
  • 8.4. HOSPITAL & PHARMACY ROBOTS

9. MEDICAL ROBOTS: BUYING CYCLE ASSESSMENT

10. MEDICAL ROBOTS: MARKETING & PROMOTIONS STRATEGIES ADOPTED BY VENDORS

  • 10.1. SURGICAL ROBOTS
  • 10.2. REHABILITATION ROBOTS
  • 10.3. NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
  • 10.4. HOSPITAL & PHARMACY ROBOTS

11. COST-BENEFIT ASSESSMENT (BASED ON RESEARCH STUDIES & EXPERT OPINIONS)

  • 11.1. SURGICAL ROBOTS
    • 11.1.1. COST-BENEFIT STUDIES
      • 11.1.1.1. A da vinci robot system can make sensefor a mature laparoscopic prostatectomy program
      • 11.1.1.2. Robot-assisted surgery compared with open surgery and laparascopic surgery: clinical effectiveness and economic analyses
    • 11.1.2. INDUSTRY SPEAKS
  • 11.2. REHABILITATION ROBOTS
    • 11.2.1. ECONOMIC IMPACT OF REHABILITATION ROBOTS VIS-A-VIS DISEASE BURDEN
    • 11.2.2. COST-BENEFIT STUDIES
      • 11.2.2.1. An economic analysis of robot-assisted therapy fro long-term upper-limb imparement after stroke
    • 11.2.3. INDUSTRY SPEAKS
  • 11.3. NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
    • 11.3.1. COST-BENEFIT STUDIES
      • 11.3.1.1. A comparative study of Gamma Knife radiosurgery versus open surgery for intracranial pathology
      • 11.3.1.2. Outcomes and cost-effectiveness of gamma knife radiosurgery and whole-brain radiotherapy for multiple metastatic brain tumors
      • 11.3.1.3. Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radition therapy in patients with 1. to 3. brain metastases
      • 11.3.1.4. Cyberknife for prostrate cancer: Is it cost-effective
      • 11.3.1.5. TomoTherapy, Gamma Knife, and Cyberknife Therapies for Patients with Tumors of the Lung, Central Nervous System, or Intra-abdomen: A Systematic Review of Clinical Effectiveness and Cost-effectiveness
    • 11.3.2. INDUSTRY SPEAKS
  • 11.4. HOSPITAL & PHARMACY ROBOTS
    • 11.4.1. COST-BENEFIT STUDIES
      • 11.4.1.1. Impact of Robotic Dispensing Machines in german Pharmacies on Business Performance Indicators
      • 11.4.1.2. Recent Trends in the Usage of Robotics in Pharmacy
      • 11.4.1.3. Cover Story - Rise of Machines
      • 11.4.1.4. Automated Medication Dispensing Systems : A Review of the Clinical Benefits, Harms, and Cost-effectiveness
    • 11.4.2. INDUSTRY SPEAKS

12. APPENDIX

  • 12.1. INDICATIVE LIST OF RESEARCH STUDIES HIGHLIGHTED ON COMPANY WEBSITES
    • 12.1.1. INTUTIVE SURGICALS
    • 12.1.2. MAZOR ROBOTICS
    • 12.1.3. VARIAN MEDICAL SYSTEMS
    • 12.1.4. ELEKTA AB
    • 12.1.5. HOCOMA AG
    • 12.1.6. REWALK
  • 12.2. SOURCES: INDICATIVE LIST OF RESEARCH STUDIES HIGHLIGHTED ON COMPANY

LIST OF TABLES

  • TABLE 1: SURGICAL ROBOTS: INDICATIVE PRICE LIST
  • TABLE 2: REHABILITATION ROBOTS: INDICATIVE PRICE LIST
  • TABLE 3: NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOTIC-BASED): INDICATIVE PRICE LIST
  • TABLE 4: HOSPITAL & PHARMACY ROBOTS: INDICATIVE PRICE LIST
  • TABLE 5: SURGICAL ROBOTS: PRICE VARIATION, BY APPLICATION
  • TABLE 6: VARIOUS SPECIFICATIONS FOR DA VINCI XI, SI, AND SI-E
  • TABLE 7: PRICE VARIATIONS FOR NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED), BY BRAND
  • TABLE 8: PRICE VARIATIONS FOR SURGICAL ROBOTS, BY GEOGRAPHY
  • TABLE 9: PRICE VARIATIONS FOR REHABILITATION ROBOTS, BY GEOGRAPHY
  • TABLE 10: PRICE VARIATIONS FOR HOSPITAL & PHARMACY ROBOTS, BY GEOGRAPHY
  • TABLE 11: CYBERKNIFE INSTALLATION, BY REGION
  • TABLE 12: GAMMA KNIFE INSTALLATION, BY REGION
  • TABLE 13: APPROXIMATE CYBERKNIFE & GAMMA KNIFE PROCEDURE COST, BY REGION
  • TABLE 14: SURGICAL ROBOTS: PRICE WAR COMPETITION ANALYSIS
  • TABLE 15: REIMBURSEMENT DETAILS: CHANGES IN TOTAL GLOBAL PAYMENT FOR SINGLE SESSION EXTRACRANIAL AND MULTISESSION SRS (STEREOTACTIC RADIOSURGERY)/SBRT (STEREOTACTIC BODY RADIATION THERAPY)
  • TABLE 16: AVERAGE AND INCREMENTAL PER-PATIENT COSTS OF ROBOT ASSISTED RADICAL PROSTATECTOMY (RARP), OPEN RADICAL PROSTATECTOMY (ORP), AND LAPAROSCOPIC RADICAL PROSTATECTOMY (LRP)
  • TABLE 17: UNDISCOUNTED PER CENTER COSTS OF DA VINCI ROBOT, MAINTENANCE, CONSUMABLES, AND TRAINING, BY YEAR
  • TABLE 18: SHARE OF ROAD TRAFFIC INURIES MORTALITY IN LEADING CAUSE OF DEATHS WORLD-WIDE 2004
  • TABLE 19: SHARE OF ROAD TRAFFIC INURIES MORTALITY IN LEADING CAUSE OF DEATHS WORLD-WIDE 2030
  • TABLE 20: HOURLY REHABILITATION ROBOT COST
  • TABLE 21: HOURLY PHYSIOTHERAPIST COST
  • TABLE 22: HOURLY ROBOT-AIDED THERAPY COST (INCLUDING PHYSIOTHERAPIST COST)
  • TABLE 23: COMPARISON OF ROBOT-ASSISTED REAHBILITATION THERAPY AND CONVENTIONAL THERAPY
  • TABLE 24: A COMPARISON OF AVERAGE 12 MONTH COSTS OF TREATING PATIENTS WITH OPEN AND GAMMA KNIFE RADIOSURGERY (GKRS)
  • TABLE 25: A COMPARISON OF GAMMA KNIFE RADIOSURGERY (GKRS) AND WHOLE BRAIN RADIOTHERAPY (WBRT)
  • TABLE 26: A COMPARISON OF 'STEREOTACTIC RADIOSURGERY (SRS)+ OBSERVATION' AND 'SRS + WHOLE BRAIN RADIATION THERAPY (WBRT)'
  • TABLE 27: A COMPARISON OF TOTAL LIFETIME COSTS OF SURGERY, CYBERKNIFE (CK), INTENSITY MODULATED RADIATION THERAPY (IMRT), AND PROTON THERAPY (PT)
  • TABLE 28: A COMPARISON OF BASE CASE AVERAGE CAPITAL EQUIPMENT COSTS PER PATIENT FOR GAMMA KNIFE (GK), CYBERKNIFE (CK), AND OTHER LINAC SYSTEMS
  • TABLE 29: SAMPLE CALCULATION OF THE TOTAL COSTS OF A ROBOTIC DISPENSING MACHINE
  • TABLE 30: COMPARISON OF ROWA VMAX, GO.COMPACT, ROBOPHARMA, AND CONSIS
  • TABLE 31: RELATIVE RISK REDUCTION (RRR) OR RELATIVE RISK INCREASE (RRI) COMPARISON OF AUTOMATED DISPENSING DEVICES (ADD) IN DIFFERENT SET-UPS
  • TABLE 32: FIVE-YEAR DRUG DISTRIBUTION COSTS OF AUTOMATED DISPENSING DEVICES (ADD)
  • TABLE 33: ACCURACY RATES BEFORE AND AFTER IMPLEMENTATION OF A CAROUSEL DISPENSING TECHNOLOGY (CDT)

LIST OF FIGURES

  • FIGURE 1: MEDICAL ROBOTS: A HISTORICAL TIMELINE
  • FIGURE 2: MEDICAL ROBOTS, BY PRODUCT SEGMENTATION
  • FIGURE 3: FACTORS RESPONSIBLE FOR PRICE VARIATION IN MEDICAL ROBOTS
  • FIGURE 4: SURGICAL ROBOTS: PRICE VARIATION, BY APPLICATION
  • FIGURE 5: PRICE VARIATIONS FOR LAPAROSCOPY ROBOTS, BY BRAND
  • FIGURE 6: PRICE VARIATIONS FOR DA VINCI ROBOTS, BY TYPE
  • FIGURE 7: PRICE VARIATIONS FOR STEERABLE ROBOTIC CATHETER SYSTEMS, BY BRAND
  • FIGURE 8: PRICE VARIATIONS FOR NEUROLOGY ROBOTS, BY BRAND
  • FIGURE 9: PRICE VARIATIONS FOR ORTHOPEDIC ROBOTS, BY BRAND
  • FIGURE 10: PRICE VARIATIONS FOR REHABILITATION ROBOTS, BY TYPE & BRAND
  • FIGURE 11: MEDICAL ROBOTS: MAJOR PRICE DETERMINANTS
  • FIGURE 12: MEDICAL ROBOTS: FINANCING OPTIONS ASSESSMENT, BY TYPE
  • FIGURE 13: MEDICAL ROBOTS: KEY STAKEHOLDERS IN PURCHASE DECISION, BY TYPE
  • FIGURE 14: MEDICAL ROBOTS: KEY INFLUNCERS & DECISION-MAKERS
  • FIGURE 15: MEDICAL ROBOTS: KEY SELECTION CRITERIA FOR END-USER, BY TYPE
  • FIGURE 16: MEDICAL ROBOTS: BUYING CYCLE ASSESSMENT, BY TYPE
  • FIGURE 17: MEDICAL ROBOTS: MARKETING & PROMOTIONS STRATEGIES, BY TYPE
  • FIGURE 18: SURGICAL ROBOTS: INDUSTRY SPEAKS
  • FIGURE 19: REHABILITATION ROBOTS: INDUSTRY SPEAKS
  • FIGURE 20: NON-INVASIVE RADIOSURGICAL SYSTEMS (ROBOT-BASED): INDUSTRY SPEAKS
  • FIGURE 21: HOSPITAL & PHARMACY ROBOTS: INDUSTRY SPEAKS
Back to Top